cialis tablets for sale Between October 2012 and October 2013, based on compelling evidence of benefit shown in clinical trials, the US Food and Drug Administration FDA approved nine new anticancer drugs to treat patients with advanced and or treatment resistant chronic myeloid leukemia CML; omacetaxine mepesuccinate and ponatinib, multiple myeloma pomalidomide, medullary thyroid cancer cabozantinib, breast cancer ado trastuzumab emtansine, prostate cancer radium 223 223 Ra dichloride, melanoma dabrafenib and trametinib, and non small cell lung cancer NSCLC; afatinib